Richard Nkulikiyinka, MD

Article

Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial

Author:

Stephen Tyring, MD, PhD

James A. Solomon, MD, PhD

Gerald Staedtler, MSc

Jason P. Lott, MD, MSHP, MHS

Richard Nkulikiyinka, MD

Kaweh Shakery, MD

Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind,...

• Read More